$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000162828020005340 Filed on April 23, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$2.172M	$3.123M
YoY Change	-30.45%	-36.82%
Cost Of Revenue	$620.2K	$2.324M
YoY Change	-73.32%	-21.35%
Gross Profit	$1.552M	$798.7K
YoY Change	94.3%	-59.82%
Gross Profit Margin	71.45%	25.58%
Selling, General & Admin	$1.676M	$3.645M
YoY Change	-54.01%	-15.41%
% of Gross Profit	108.01%	456.34%
Research & Development	$533.6K	$855.1K
YoY Change	-37.59%	-33.17%
% of Gross Profit	34.39%	107.06%
Depreciation & Amortization	$23.41K	$31.78K
YoY Change	-26.34%	-42.68%
% of Gross Profit	1.51%	3.98%
Operating Expenses	$2.210M	$4.500M
YoY Change	-50.89%	-19.48%
Operating Profit	-$657.9K	-$3.701M
YoY Change	-82.23%	2.79%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	$20.00K
YoY Change	-100.0%	100.0%
Pretax Income	-$660.0K	$2.050M
YoY Change	-132.2%	75.21%
Income Tax
% Of Pretax Income
Net Earnings	-$657.4K	$2.051M
YoY Change	-132.06%	75.82%
Net Earnings / Revenue	-30.27%	65.66%
Basic Earnings Per Share	-$0.45	$2.65
Diluted Earnings Per Share	-$0.45	$1.47
COMMON SHARES
Basic Shares Outstanding	1.457M shares	774.1K shares
Diluted Shares Outstanding	1.457M shares	1.397M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.820M	$7.200M
YoY Change	-60.83%	18.03%
Cash & Equivalents	$2.816M	$7.201M
Short-Term Investments
Other Short-Term Assets	$340.0K	$960.0K
YoY Change	-64.58%	1.05%
Inventory	$1.154M	$2.494M
Prepaid Expenses
Receivables	$386.1K	$972.4K
Other Receivables	$180.0K	$0.00
Total Short-Term Assets	$4.878M	$11.63M
YoY Change	-58.06%	10.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$250.0K	$375.6K
YoY Change	-33.42%	-13.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$30.00K
YoY Change	0.0%	-25.0%
Total Long-Term Assets	$1.329M	$2.277M
YoY Change	-41.64%	379.48%
TOTAL ASSETS
Total Short-Term Assets	$4.878M	$11.63M
Total Long-Term Assets	$1.329M	$2.277M
Total Assets	$6.206M	$13.91M
YoY Change	-55.37%	26.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$623.2K	$557.9K
YoY Change	11.71%	45.25%
Accrued Expenses	$1.065M	$3.036M
YoY Change	-64.94%	28.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.882M	$4.503M
YoY Change	-35.99%	8.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$810.0K	$1.210M
YoY Change	-33.06%
Total Long-Term Liabilities	$810.0K	$1.210M
YoY Change	-33.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.882M	$4.503M
Total Long-Term Liabilities	$810.0K	$1.210M
Total Liabilities	$3.692M	$5.714M
YoY Change	-35.38%	37.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$195.4M	-$189.0M
YoY Change	3.4%	-0.49%
Common Stock	$168.00	$831.00
YoY Change	-79.78%	16.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.514M	$8.192M
YoY Change
Total Liabilities & Shareholders Equity	$6.206M	$13.91M
YoY Change	-55.37%	26.74%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$657.4K	$2.051M
YoY Change	-132.06%	75.82%
Depreciation, Depletion And Amortization	$23.41K	$31.78K
YoY Change	-26.34%	-42.68%
Cash From Operating Activities	-$763.2K	$420.4K
YoY Change	-281.55%	-79.79%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$453.5K	$0.00
YoY Change
NET CHANGE
Cash From Operating Activities	-$763.2K	$420.4K
Cash From Investing Activities	$0.00	$0.00
Cash From Financing Activities	$453.5K	$0.00
Net Change In Cash	-$309.7K	$420.4K
YoY Change	-173.68%	-79.54%
FREE CASH FLOW
Cash From Operating Activities	-$763.2K	$420.4K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$763.2K	$420.4K
YoY Change	-281.55%	-79.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	City Area Code CityAreaCode	781
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	0	USD
CY2020Q1	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	-7678	USD
CY2019Q4	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	189008	USD
CY2020Q1	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	181330	USD
CY2019Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-374766	USD
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2736207	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity File Number EntityFileNumber	001-33351
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	043308180
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	890-9989
CY2020Q1	dei	Trading Symbol TradingSymbol	NURO
CY2019Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	689000	USD
CY2020Q1	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	603000	USD
CY2019Q1	nuro	Collaboration Income CollaborationIncome	5734849	USD
CY2020Q1	nuro	Collaboration Income CollaborationIncome	0	USD
CY2019Q1	nuro	Compensation Obligation Settlement CompensationObligationSettlement	0	USD
CY2020Q1	nuro	Compensation Obligation Settlement CompensationObligationSettlement	43751	USD
CY2019	nuro	Facility Relocation Costs FacilityRelocationCosts	100000	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	487000	USD
CY2019Q1	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	0	USD
CY2020Q1	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	87000	USD
CY2020Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-86000	USD
CY2019Q1	nuro	Increase Decreasein Deferred Collaboration Income IncreaseDecreaseinDeferredCollaborationIncome	-1774704	USD
CY2020Q1	nuro	Increase Decreasein Deferred Collaboration Income IncreaseDecreaseinDeferredCollaborationIncome	0	USD
CY2020Q1	nuro	Operating Lease Discount OperatingLeaseDiscount	430298	USD
CY2020Q1	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
CY2019Q1	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
CY2020Q1	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	43751	USD
CY2019Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2020Q1	nuro	Technology Fees TechnologyFees	450000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	725658	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	623193	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	298967	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	386124	USD
CY2019Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	68000	USD
CY2020Q1	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	60000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1443574	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1064580	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	454000	USD
CY2020Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	292000	USD
CY2019Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	62322	USD
CY2020Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	92758	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197319698	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197960925	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44093	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	144047	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70000	USD
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	94786	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	206239	shares
CY2019Q4	us-gaap	Assets Assets	6893686	USD
CY2020Q1	us-gaap	Assets Assets	6206496	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	5430814	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	4877868	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3126206	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2816485	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6780429	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7200795	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3126206	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2816485	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	420366	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-309721	USD
CY2020Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	41627	shares
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1400674	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1687752	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1400674	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1687752	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	140	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	168	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	2324231	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	620190	USD
CY2019Q1	us-gaap	Depreciation Depreciation	31778	USD
CY2020Q1	us-gaap	Depreciation Depreciation	23407	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.65
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.47
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	408144	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P9M18D
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1619490	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1251746	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	798704	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	1551846	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-740223	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-102465	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-110605	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	87157	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	657059	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-458772	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	182404	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10154	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	101579	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-312550	USD
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	622720	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	443505	USD
CY2020Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	416769	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1163714	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	1153560	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	720209	USD
CY2020Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	736791	USD
CY2019Q1	us-gaap	Inventory Write Down InventoryWriteDown	700000	USD
CY2020Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	166024	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	166904	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1831903	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	117431	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	482391	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	165785	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165785	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	247347	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	653164	USD
CY2019Q4	us-gaap	Liabilities Liabilities	4363452	USD
CY2020Q1	us-gaap	Liabilities Liabilities	3692378	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6893686	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6206496	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3446778	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2882143	USD
CY2020Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2020-04-30
CY2020Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	250000	USD
CY2020Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	0	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	106122	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	453457	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	420366	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-763178	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	2050507	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-657371	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2050507	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-657371	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	4499859	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	2209715	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3701155	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-657869	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	588546	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	591370	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	916674	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	810235	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1159774	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1048937	USD
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.15
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	333952	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q1	us-gaap	Other Income OtherIncome	16813	USD
CY2020Q1	us-gaap	Other Income OtherIncome	498	USD
CY2019Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5751662	USD
CY2020Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	498	USD
CY2020Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	4000000	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	USD
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	652919	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	340369	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	29650	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	29650	USD
CY2019Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	453457	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	75300	USD
CY2020Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	63700	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	2050507	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-657371	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273448	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	250041	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	855081	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	533620	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-195446976	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	2300000	USD
CY2020Q1	us-gaap	Restructuring Reserve RestructuringReserve	400000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194789605	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-195400000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3122935	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2172036	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2025288	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	424349	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	224773	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	44093	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	144047	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	453457	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	43751	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	6097811	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	8192411	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2530234	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2514118	USD
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
CY2020Q1	us-gaap	Substantial Doubt About Going Concern Within One Year SubstantialDoubtAboutGoingConcernWithinOneYear	true
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1396866	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1457224	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	774146	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1457224	shares
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-20-005340-index-headers.html	Edgar Link	pending
0001628280-20-005340-index.html	Edgar Link	pending
0001628280-20-005340.txt	Edgar Link	pending
0001628280-20-005340-xbrl.zip	Edgar Link	pending
a10q3312020document.htm	Edgar Link	pending
a10q3312020ex101.htm	Edgar Link	pending
a10q3312020ex311.htm	Edgar Link	pending
a10q3312020ex312.htm	Edgar Link	pending
a10q3312020ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nuro-20200331.xml	Edgar Link	completed
nuro-20200331.xsd	Edgar Link	pending
nuro-20200331_cal.xml	Edgar Link	unprocessable
nuro-20200331_def.xml	Edgar Link	unprocessable
nuro-20200331_lab.xml	Edgar Link	unprocessable
nuro-20200331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2020 Q1 Form 10-Q Financial Statement

#000162828020005340 Filed on April 23, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2020 Q1 Form 10-Q Financial Statement

#000162828020005340 Filed on April 23, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro